# Spry Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spry-therapeutics

- Industry: Software
- Headquarters: Wilmington, US
- Website: www.sprypt.com
- Total disclosed funding: $25M
- Latest round: Series A (Oct 9, 2024)
- Investors on record: 9

## About

Spry Therapeutics Inc., based in the US, provides innovative software solutions to enhance operations in physical therapy, occupational therapy, and speech-language pathology practices, focusing on improving patient care through streamlined management tools.Spry Therapeutics Inc. specializes in developing software solutions that improve operational efficiencies for therapy clinics. Founded in 2021 and headquartered in Wilmington, US, the company has successfully completed 3 deals. Its latest funding round was a Series A, raising USD 15.00 mn led by Flourish Ventures, with participation from Eight Roads Ventures, F-Prime Capital, and Together. The total amount raised to date is USD 15.00 mn, and the current company valuation stands at USD 54.77 mn. The company was co-founded by Bill Purdy and Bob Purdy, who have extensive experience in the software and healthcare sectors.SPRY specializes in providing comprehensive software solutions tailored for physical therapy (PT), occupational therapy (OT), and speech-language pathology (SLP) practices. Their flagship offerings include a cloud-based practice management system designed to streamline operations for clinics by integrating scheduling, billing, and telehealth functionalities. This software alleviates common challenges faced by growing clinics, such as fragmented tools and high overhead costs. SPRY's client base includes independent PT practices, rehabilitation centers, and multi-disciplinary clinics primarily in North America and parts of Europe, enhancing patient care and operational efficiency while minimizing administrative burdens.SPRY generates revenue primarily through a subscription-based model with tiered pricing plans based on the features selected by clients. This structure allows clinics to choose packages that meet their operational needs, with options for annual or monthly billing cycles. Their pricing framework includes features like advanced reporting and integration capabilities, catering to various user requirements. By establishing direct relationships with healthcare providers, SPRY ensures a consistent revenue stream while contributing directly to improved patient management and care delivery.In October 2024, Spry Therapeutics Inc. secured USD 15.00 mn in Series A funding led by Flourish Ventures. The company plans to utilize this funding to support its expansion within the US market. This includes the design and launch of new products aimed at enhancing their software offerings, although specific release dates have not been disclosed. Spry Therapeutics is strategically positioned to increase its market presence, building on its foundation to better serve healthcare providers as it continues to grow.

## Funding rounds

- Series A, Oct 9, 2024, $15M — Eight Roads Ventures, F-Prime Capital, Flourish Ventures, Together
- Series A, Jun 22, 2022, $7M — Eight Roads Ventures, F-Prime Capital, Together
- Seed, Dec 14, 2021, $3M — FJ Labs, Whiteboard Capital, Pareto Holdings, Knowledge Capital, Together, AngelList

## Investors

- FJ Labs (https://capitalatlas.ai/funds/fj-labs) — Seed
- Whiteboard Capital (https://capitalatlas.ai/funds/whiteboard-capital) — Seed
- Pareto Holdings (https://capitalatlas.ai/funds/pareto-holdings) — Seed
- Knowledge Capital — Seed
- Together (https://capitalatlas.ai/funds/together) — Seed, Series A
- AngelList — Seed
- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series A
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A
- Flourish Ventures (https://capitalatlas.ai/funds/flourish-ventures) — Series A